| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,264 |
9,655 |
$685K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,130 |
2,725 |
$252K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,353 |
2,109 |
$145K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,142 |
1,956 |
$130K |
| 92587 |
|
2,973 |
2,661 |
$105K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,963 |
4,389 |
$97K |
| 99215 |
Prolong outpt/office vis |
715 |
569 |
$79K |
| 92081 |
|
2,801 |
2,506 |
$76K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,311 |
1,191 |
$76K |
| 99460 |
|
1,021 |
863 |
$73K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,083 |
990 |
$64K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,721 |
4,219 |
$59K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
917 |
765 |
$51K |
| 90698 |
|
1,900 |
1,715 |
$33K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,509 |
3,184 |
$32K |
| 90670 |
|
1,701 |
1,536 |
$30K |
| 99462 |
|
880 |
543 |
$25K |
| 90744 |
|
1,388 |
1,252 |
$25K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
752 |
618 |
$18K |
| 87807 |
|
1,549 |
1,376 |
$15K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
419 |
327 |
$12K |
| 90633 |
|
504 |
471 |
$9K |
| 90716 |
|
505 |
470 |
$9K |
| 90707 |
|
494 |
457 |
$9K |
| 90681 |
|
426 |
380 |
$7K |
| 90734 |
|
245 |
232 |
$4K |
| 90651 |
|
216 |
208 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
101 |
96 |
$2K |
| 92567 |
|
187 |
170 |
$2K |
| 90715 |
|
108 |
102 |
$2K |
| 0001A |
|
100 |
83 |
$1K |
| 90658 |
|
89 |
83 |
$1K |
| D1206 |
Topical application of fluoride varnish |
147 |
129 |
$1K |
| 90677 |
|
79 |
69 |
$1K |
| 0002A |
|
66 |
56 |
$930.13 |
| 86677 |
|
54 |
49 |
$864.00 |
| 90696 |
|
44 |
42 |
$831.18 |
| 94664 |
|
88 |
79 |
$740.00 |
| 86308 |
|
106 |
99 |
$588.00 |
| 0011A |
|
31 |
30 |
$440.60 |
| 90657 |
|
16 |
15 |
$316.64 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
13 |
13 |
$183.30 |
| 81002 |
|
42 |
36 |
$102.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
67 |
61 |
$85.26 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
305 |
276 |
$52.21 |
| 87634 |
|
22 |
15 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
12 |
12 |
$0.00 |